EvoVera Moisturizing Cream
High-potency topical peptide cream containing 1,000 mg SNAP-8® (acetyl octapeptide-3) and 200 mg GHK-Cu (copper tripeptide-1) per jar. Formulated in a moisturizing base with beeswax, royal jelly extract, and honey-derived ingredients for controlled topical application studies.
Compound Profile
Pharmaceutical Data Sheet
Mechanism of Action
How EvoVera Moisturizing Cream Works
EvoVera Moisturizing Cream combines SNAP-8® (acetyl octapeptide-3) and GHK-Cu in a moisturizing cream base. SNAP-8 is studied for its role in modulating neuromuscular junction activity in skin tissue, while GHK-Cu is investigated for extracellular matrix remodeling and collagen synthesis signaling.
- Modulates SNARE complex activity
- Studied for expression line reduction
- Acetyl octapeptide-3 analog of SNAP-25
- Activates collagen I/III synthesis genes
- Promotes extracellular matrix remodeling
- Upregulates SOD and antioxidant enzymes
SNAP-8 acts as a SNARE complex modulator, investigated for reducing the intensity of muscle contractions at the dermal level. GHK-Cu activates genes involved in collagen production, decorin synthesis, and antioxidant enzyme upregulation. Together they target both dynamic and structural aspects of skin tissue.
Based on published research on acetyl octapeptide-3 and copper tripeptide-1 mechanisms.
Preclinical Findings
Research Models
Clinical Data
Topical Peptide Delivery Research
SNAP-8 and GHK-Cu are among the most studied peptides in topical cosmeceutical research. SNAP-8 has been evaluated in multiple clinical settings for its effects on expression line depth, while GHK-Cu has extensive literature on wound healing and collagen remodeling.
Int J Cosmet Sci: Review of topical peptide efficacy in skin research models.
Published cosmeceutical peptide literature
Research Outcomes
Key Research Success Metrics
Safety Profile
Research Safety Notes
- GHK-Cu occurs naturally in human plasma — well-characterized safety profile
- SNAP-8 is widely used in cosmetic peptide formulations with no significant adverse events
- Topical peptide formulations have favorable safety profiles in dermal studies
- No systemic absorption concerns at topical application concentrations
- Both peptides have extensive published safety data in cosmeceutical literature
EvoVera Moisturizing Cream is a topical peptide research formulation. For research use only. Not intended for diagnostic or therapeutic purposes.
About EvoVera Moisturizing Cream
High-potency topical peptide cream containing 1,000 mg SNAP-8® (acetyl octapeptide-3) and 200 mg GHK-Cu (copper tripeptide-1) per jar. Formulated in a moisturizing base with beeswax, royal jelly extract, and honey-derived ingredients for controlled topical application studies.
All EVO Labs Research compounds are manufactured to research-grade standards and independently tested by Janoshik Analytical (Prague, est. 2013). The Certificate of Analysis for this compound includes full HPLC chromatography data, mass spectrometry confirmation, net purity percentage, and net content verification.
Research Use Only
This product is strictly for in vitro research and laboratory use only. Not for human or veterinary consumption. By purchasing, you confirm use in a controlled research setting.
